Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Seegene to Unveil at AACC 2014 the Innovative Real-Time PCR Technology

Published: Thursday, July 24, 2014
Last Updated: Thursday, July 24, 2014
Bookmark and Share
MuDT™ technology doubles the channel availability of any real-time PCR instrument.

Seegene Inc. has announced “MuDT™” technology, the industry’s first real-time PCR technology that will ignite a paradigm shift in the PCR instrument market.

By doubling the multiplexing capacity of any existing real-time PCR instrument, MuDT™ will maximize the value of the installed base of real-time PCR instruments.

MuDT™ technology will be unveiled at the 2014 Clinical Lab Expo of the American Association for Clinical Chemistry (AACC), held in Chicago from July 29 to 31.

The biotechnology industry has relied on real-time PCR, the gold standard in molecular diagnostics, due to its versatility, speed and ease of use. Despite many attempts over the past 20 years, the biotechnology industry has not made significant advances that satisfy the growing demand for increased multiplexing and target quantification using limited numbers of channels in a single tube.

Even melt curve analysis after amplification has many drawbacks, such as end-point analysis after amplification, extended turnaround time, lack of quantification and melt temperature variation due to target sequence variations on probe binding regions.

MuDT™ technology can be applied to any existing real-time PCR instrument and transforms it into a more powerful system by doubling its multiplexing capacity without upgrading the hardware.

Additional benefits of MuDT™ technology include:

• Easier detection of multiple targets in a single channel without requiring melt curve analysis after amplification.
• SNP genotyping (homozygous wild type or mutant, or heterozygous) in a single channel.
• Identification and quantification of multiple mutations at the same time in a single tube.
• Economical approach for high multiplexing and quantification by doubling channel availability.
• Freedom from well-to-well and instrument-to-instrument variations.

“MuDT™ is an extremely powerful technology that maximizes the usage of any existing real-time PCR instrument and that will re-invigorate the real-time PCR based market," said Dr. Chun, Jong-Yoon, Founder, CTO and CEO of Seegene. “By adopting MuDT™ technology, real-time PCR companies will be able to add great value and competitiveness to their current instruments.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Seegene and Eidia Collaborate
Through this agreement, Eidia gains access to Seegene's portfolio of TOCE™ technology-based multiplexed molecular diagnostic tests for the Japanese diagnostic test market.
Tuesday, July 09, 2013
Seegene Announces Magicplex™ RV Panel Real-Time Test
New multiplex real-time PCR test can simultaneously detect 29 respiratory viruses, including Influenza A subtypes.
Tuesday, November 02, 2010
Scientific News
Heart Arrhythmia Caused by Mosaic of Mutant Cells
Researchers have solved the genetic mystery of an infant suffering from heart arrhythmia.
Crispr Toolbox Expanded By Protein
Researchers have shown a newly discovered CRISPR protein has two distinct RNA cutting activities.
Over Two-Thirds of Cervical Cancer Deaths Prevented
Cervical screening prevents 70% of cervical cancer deaths and if all eligible women regularly attended screening this would rise to 83%.
Detecting Bacterial Infections in Newborns
Researchers tested an alternative way to diagnose bacterial infections in infants—by analyzing RNA biosignatures from a small blood sample.
Mechanisms of Parkinson’s Pathology
Defects that lead to cells’ failure to decommission faulty mitochondria cause nerve cells to die, triggering the symptoms of Parkinson’s disease.
Case for Liquid Biopsies Builds in Advanced Lung Cancer
Study addresses unmet need for better, non-invasive tests called out in recent "Moonshot" blue ribbon panel report
Genetic Misdiagnoses of Heart Condition
Analysis found several genetic variations previously linked with a heart condition were harmless, leading to condition misdiagnosis.
Opening Door to Oesophageal Cancer Targeted Treatments
Scientists have discovered that oesophageal cancer can be classified into three different subtypes.
Genetic Diversity of Enzymes Alters Metabolic Individuality
ToMMo scientists have shown that genetic polymorphisms, structural location of mutation and effect for phenotype correlate with each other.
IMM Uses Nanowizard® to Evaluate Cardiovascular Disease Risk
JPK Instruments reports on the use of their NanoWizard® AFM system at the Instituto de Medicina Molecular at the University of Lisbon.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!